Plain-English translation of NCT07777926 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing Restylane Lyft, a hyaluronic acid filler, to see how well it improves the appearance and shape of the chin and lower face. Researchers will use 3D imaging to measure exactly how the treatment changes the volume and contour of your chin over three months. The study also asks participants about their satisfaction with the results.
Some people are unhappy with the shape or symmetry of their chin, and this treatment may help reshape the jawline naturally. This study will show doctors how much the medication actually changes chin volume and whether patients feel satisfied with the cosmetic results.
You likely qualify if…
You likely don't qualify if…
You will receive FDA-approved filler injections in your chin area at the first visit. Before and after the injection, researchers will take detailed 3D photographs to measure changes in chin volume. You'll return to the clinic three more times over the next three months—at 2 weeks, 1 month, and 3 months—for follow-up photos and to answer questions about how satisfied you are with the results. The entire study lasts about 90 days.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
United States
Sponsor
University of Pennsylvania
Enrollment target
~20 participants
Started
September 2026
Primary completion
December 2026
Age range
22 Years – 55 Years
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Aamirah McCutchen
University of Pennsylvania
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.